Diagnostic utility of ASL‐MRI and FDG‐PET in the behavioral variant of FTD and AD

To compare the values of arterial spin‐labeled (ASL) MRI and fluorodeoxyglucose (FDG) PET in the diagnosis of behavioral variant of frontotemporal dementia (bvFTD) and Alzheimer's disease (AD).

[1]  Mike P. Wattjes,et al.  Cerebral perfusion and glucose metabolism in Alzheimer’s disease and frontotemporal dementia: two sides of the same coin? , 2015, European Radiology.

[2]  D. Neary,et al.  18F-Florbetapir PET in Patients with Frontotemporal Dementia and Alzheimer Disease , 2015, The Journal of Nuclear Medicine.

[3]  Pradeep Reddy Raamana,et al.  Three-Class Differential Diagnosis among Alzheimer Disease, Frontotemporal Dementia, and Controls , 2014, Front. Neurol..

[4]  S. Kushwaha,et al.  Differential Diagnosis of Neurodegenerative Dementias Using Metabolic Phenotypes on F-18 FDG PET/CT , 2014, The neuroradiology journal.

[5]  Annals of Clinical and Translational Neurology , 2014, Annals of clinical and translational neurology.

[6]  P. Scheltens,et al.  Impact of molecular imaging on the diagnostic process in a memory clinic , 2013, Alzheimer's & Dementia.

[7]  Cindee M. Madison,et al.  Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. , 2013, Brain : a journal of neurology.

[8]  D. Geschwind,et al.  Frontotemporal dementia due to C9ORF72 mutations , 2012, Neurology.

[9]  B. Miller,et al.  Cognition, glucose metabolism and amyloid burden in Alzheimer's disease , 2012, Neurobiology of Aging.

[10]  Janet S. Reddin,et al.  Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease , 2012, Alzheimer's & Dementia.

[11]  N. Bohnen,et al.  Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature , 2012, The Journal of Nuclear Medicine.

[12]  J. Kornak,et al.  Amyloid Vs Fdg-pet in the Differential Diagnosis of Ad And , 2022 .

[13]  Janet S. Reddin,et al.  Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease , 2011, Neurology.

[14]  Nick C Fox,et al.  Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.

[15]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[16]  Wang Zhan,et al.  Joint Assessment of Structural, Perfusion, and Diffusion MRI in Alzheimer's Disease and Frontotemporal Dementia , 2011, International journal of Alzheimer's disease.

[17]  Karsten Mueller,et al.  Combined Evaluation of FDG-PET and MRI Improves Detection and Differentiation of Dementia , 2011, PloS one.

[18]  K. Rankin,et al.  The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. , 2011, The Journal of clinical psychiatry.

[19]  Arno Klein,et al.  A reproducible evaluation of ANTs similarity metric performance in brain image registration , 2011, NeuroImage.

[20]  John A. Detre,et al.  Clinical neuroimaging using arterial spin-labeled perfusion magnetic resonance imaging , 2007, Neurotherapeutics.

[21]  J. Trojanowski,et al.  Distinct cerebral perfusion patterns in FTLD and AD , 2010, Neurology.

[22]  Norbert Schuff,et al.  Joint analysis of structural and perfusion MRI for cognitive assessment and classification of Alzheimer's disease and normal aging , 2010, NeuroImage.

[23]  D. Knopman,et al.  Vascular risk factors: imaging and neuropathologic correlates. , 2010, Journal of Alzheimer's disease : JAD.

[24]  J Nucl Med , 2010 .

[25]  Bruce Fischl,et al.  Accurate and robust brain image alignment using boundary-based registration , 2009, NeuroImage.

[26]  Alain Giron,et al.  Differential automatic diagnosis between Alzheimer's disease and frontotemporal dementia based on perfusion SPECT images , 2009, Artif. Intell. Medicine.

[27]  B L Miller,et al.  CHARACTERIZING RADIOLOGY REPORTS IN PATIENTS WITH FRONTOTEMPORAL DEMENTIA , 2009, Neurology.

[28]  Hans Brunnström,et al.  Prevalence of dementia subtypes: a 30-year retrospective survey of neuropathological reports. , 2009, Archives of gerontology and geriatrics.

[29]  Ron Dumont,et al.  Delis‐Kaplan Executive Function System , 2008 .

[30]  C. DeCarli,et al.  FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. , 2007, Brain : a journal of neurology.

[31]  C. DeCarli,et al.  What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? , 2007, Neurology.

[32]  M. Mendez,et al.  Accuracy of the clinical evaluation for frontotemporal dementia. , 2007, Archives of neurology.

[33]  Andrew Kertesz,et al.  The Diagnosis and Course of Frontotemporal Dementia , 2007, Alzheimer disease and associated disorders.

[34]  N. Schuff,et al.  Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI , 2006, Neurology.

[35]  F. Mishkin,et al.  Variations in regional SPECT hypoperfusion and clinical features in frontotemporal dementia , 2006, Neurology.

[36]  A. Hofman,et al.  Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam study , 2005, Annals of neurology.

[37]  J. S. Lee,et al.  18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[38]  A. Drzezga,et al.  Region-Specific Decline of Cerebral Glucose Metabolism in Patients with Frontotemporal Dementia: A Prospective 18F-FDG-PET Study , 2004, Dementia and Geriatric Cognitive Disorders.

[39]  Howard J. Rosen,et al.  Distinctive Neuropsychological Patterns in Frontotemporal Dementia, Semantic Dementia, And Alzheimer Disease , 2003, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[40]  Philip Scheltens,et al.  Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. , 2003, Brain : a journal of neurology.

[41]  J R Hodges,et al.  The prevalence of frontotemporal dementia , 2002, Neurology.

[42]  L. Defebvre,et al.  Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to 99mTc HmPAO SPECT data , 2000, Journal of neurology, neurosurgery, and psychiatry.

[43]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[44]  D. Neary,et al.  Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer’s disease and frontotemporal dementia , 1999, Journal of neurology, neurosurgery, and psychiatry.

[45]  K. Ishii,et al.  Cerebral glucose metabolism in patients with frontotemporal dementia. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[46]  N. Foster,et al.  Preserved Pontine Glucose Metabolism in Alzheimer Disease: A Reference Region for Functional Brain Image (PET) Analysis , 1995, Journal of computer assisted tomography.

[47]  M. Jüptner,et al.  Review: Does Measurement of Regional Cerebral Blood Flow Reflect Synaptic Activity?—Implications for PET and fMRI , 1995, NeuroImage.

[48]  J. Morris.  The Clinical Dementia Rating (CDR) , 1993, Neurology.

[49]  Jerry L Prince,et al.  Measurement of Radiotracer Concentration in Brain Gray Matter Using Positron Emission Tomography: MRI-Based Correction for Partial Volume Effects , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[50]  Dr. Ron Short.  Diagnosis? , 1987, The Lancet.

[51]  S. Wold,et al.  Multi‐way principal components‐and PLS‐analysis , 1987 .

[52]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[53]  E. Kaplan,et al.  The Boston naming test , 2001 .

[54]  I. Jolliffe.  A Note on the Use of Principal Components in Regression , 1982 .

[55]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.

[56]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[57]  R. Reitan.  Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .

[58]  Q. Mcnemar.  Note on the sampling error of the difference between correlated proportions or percentages , 1947, Psychometrika.